Castle Biosciences Inc. (CSTL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Castle Biosciences Inc., updated every trading day.
Health Care · Medical Specialities
Price
$36.68
+6.29% today
Market cap
$1.1B
Overall quality
56/100
Kronos AI 30-day
−14.2%
0 of 8 simulated paths end higher
Castle Biosciences Inc. (CSTL) is a Health Care company in Medical Specialities, worth $1.1B. It trades at $36.68, up 6.29% today. Its overall quality score is 56 out of 100, ranked against the whole US market. 5 analysts' average target of $45.40 implies +23.8% from today's price. Kronos AI's 30-day forecast is −14.2% (0 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $45.40 |
| Low – high | $36.00 – $57.00 |
| Analysts | 5 |
| Upside to average | +23.8% |
Kronos AI 30-day forecast
| Expected close | $29.63 (−14.2%) |
| Likely range | −23.4% … −6.3% |
| As of | 2026-10-27 |
0 of 8 simulated paths end higher.
Quality scores
| Profitability | 31 |
| Solvency | 58 |
| Growth | 80 |
| Overall | 56 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Medical Specialities
For information only, not investment advice. Prices updated: 2026-10-29.